🇺🇸 FDA
Patent

US 9763993

Process for manufacturing glatiramer acetate product

granted A61KA61K38/02A61K38/03

Quick answer

US patent 9763993 (Process for manufacturing glatiramer acetate product) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K38/02, A61K38/03, A61K38/16, A61K47/26